# Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

> **NCT02357459** · PHASE3 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 486 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** FX006
- **DRUG:** Placebo
- **DRUG:** TCA IR 40

## Key facts

- **NCT ID:** NCT02357459
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 486 (ACTUAL)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02357459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02357459, "Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02357459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*